Home » Topics » Regulatory » Patents

Patents
RSS

Guangzhou Institutes of Biomedicine and Health presents novel RORC antagonists

Aug. 11, 2017

Sumitomo Dainippon Pharma divulges new semaphorin-3A inhibitors

Aug. 11, 2017

Beijing Marino Biotechnology describes a transgenic lymphocyte construct identifying EGFRvIII

Aug. 11, 2017

Yeda Research & Development patents protein LYRIC/transcription factor p65 interaction inhibitors

Aug. 11, 2017

Shanghai Institute Materia Medica, Sunnylife Pharma disclose BTK inhibitors

Aug. 10, 2017

Merck & Co. patents anti-coagulation factor XI antibodies

Aug. 10, 2017

Servier, Vernalis divulge novel Mcl-1 inhibitors

Aug. 10, 2017

American Gene Technologies International presents farnesyl diphosphate synthase inhibitors

Aug. 10, 2017

Taipei Medical University identifies new niclosamide prodrugs

Aug. 10, 2017

Nippon Chemiphar, Kinki University describe novel calcium channel subunit alpha Cav3.2 blockers

Aug. 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...